Advertisement

Phytotherapy in chronic prostatitis

  • Daniel A. Shoskes
    Correspondence
    Correspondence: Daniel A. Shoskes, MD, Cleveland Clinic Florida, 2950 Cleveland Clinic Boulevard, Weston, Florida 33331, USA. Reprints are not available.
    Affiliations
    Cleveland Clinic Florida, Weston, Florida, USA
    Search for articles by this author

      Abstract

      Chronic prostatitis is a very common condition that is poorly understood and has a significant impact on quality of life. Given the lack of proven efficacy of conventional therapies, such as antibiotics, it is not surprising that patients have turned with increasing frequency to phytotherapy and other alternative treatments. Although alternative therapies are plentiful, few have been subjected to scientific scrutiny and prospective controlled clinical trials. This review will cover phytotherapies commonly used in prostatitis patients and focus in detail on those with published data. These treatments include zinc, cernilton (bee pollen), quercetin, and saw palmetto. Although many of these therapies appear promising in small preliminary studies, phytotherapy requires the same scientific criteria for validation and acceptance as do conventional medical therapies.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ruschitzka F.
        • Meier P.J.
        • Turina M.
        • et al.
        Acute heart transplant rejection due to Saint John’s wort.
        Lancet. 2000; 355: 548-549
        • Wilt T.J.
        • Ishani A.
        • Rutks I.
        • et al.
        Phytotherapy for benign prostatic hyperplasia.
        Public Health Nutr. 2000; 3: 459-472
      1. Wilt T, Mac Donald R, Ishani A, et al: Cernilton for benign prostatic hyperplasia. Cochrane Database Syst Rev CD001042, 2000

        • Vanderhoof J.A.
        Probiotics.
        Am J Clin Nutr. 2001; 73: 1152S-1155S
        • Lowe F.C.
        • Fagelman E.
        Cranberry juice and urinary tract infections.
        Urology. 2001; 57: 407-413
        • Reid G.
        • Hsiehl J.
        • Potter P.
        • et al.
        Cranberry juice consumption may reduce biofilms on uroepithelial cells.
        Spinal Cord. 2001; 39: 26-30
        • Mardh P.A.
        • Colleen S.
        Antimicrobial activity of human seminal fluid.
        Scand J Urol Nephrol. 1975; 9: 17-23
        • Fair W.R.
        • Couch J.
        • Wehner N.
        Prostatic antibacterial factor. Identity and significance.
        Urology. 1976; 7: 169-177
        • Alexander R.B.
        • Ponniah S.
        • Hasday J.
        • et al.
        Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome.
        Urology. 1998; 52: 744-749
        • Shahed A.R.
        • Shoskes D.A.
        Oxidative stress in prostatic fluid of patients with chronic pelvic pain syndrome.
        J Androl. 2000; 21: 669-675
        • Nadler R.B.
        • Koch A.E.
        • Calhoun E.A.
        • et al.
        IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis.
        J Urol. 2000; 164: 214-218
        • Hochreiter W.W.
        • Nadler R.B.
        • Koch A.E.
        • et al.
        Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions.
        Urology. 2000; 56: 1025-1029
        • Buck A.C.
        • Rees R.W.
        • Ebeling L.
        Treatment of chronic prostatitis and prostatodynia with pollen extract.
        Br J Urol. 1989; 64: 496-499
        • Rugendorff E.W.
        • Weidner W.
        • Ebeling L.
        • et al.
        Results of treatment with pollen extract (cernilton N) in chronic prostatitis and prostatodynia.
        Br J Urol. 1993; 71: 433-438
        • Hollman P.C.
        • Katan M.B.
        Bioavailability and health effects of dietary flavonols in man.
        Arch Toxicol. 1998; 20: 237-248
        • Sato M.
        • Miyazaki T.
        • Kambe F.
        • et al.
        Quercetin, a bioflavonoid, inhibits the induction of interleukin 8 and monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha in cultured human synovial cells.
        J Rheumatol. 1997; 24: 1680-1684
        • Shoskes D.
        Use of the bioflavonoid quercetin in patients with long-standing chronic prostatitis.
        J Am Neutraceut Assoc. 1999; 2: 18-21
        • Shoskes D.A.
        • Zeitlin S.I.
        • Shahed A.
        • et al.
        Quercetin in men with category III chronic prostatitis.
        Urology. 1999; 54: 960-963
        • Volpe M.A.
        • Cabelin M.
        • Te A.E.
        • et al.
        A prospective trial using saw palmetto versus finasteride in the treatment of chronic nonbacterial prostatitis (CP).
        J Urol. 2001; 165: 27-28
        • Jia Y.
        • Li Y.
        • Li J.
        • et al.
        Treatment of nonspecific chronic prostatitis with Qian Lie Xian Yan Suppository suppository in 104 cases.
        J Tradit Chin Med. 2001; 21: 90-92

      Linked Article